Lapasanda, Mark Jesser C.
HRN: 04-36-88 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/28/2026
07/05/2026
IV
500
Q6
Intestinal Amoebiasis
Checking Initial Appropriateness